CTSD and type 2 diabetes mellitus: Results: Two-way ANOVA revealed that Type 2 diabetes significantly increased the levels of Beclin-1, Fyco-1, and cathepsin D (p < 0.001) while significantly reducing the levels of mTOR and pmTOR (p < 0.001).